Organon (OGN) Operating Expenses (2020 - 2026)
Organon (OGN) posted quarterly Operating Expenses of $524.0 million for Q2 2026, down 4.73% year-over-year from $550.0 million in Q2 2025, and down 4.38% on a QoQ basis from $548.0 million in Q1 2026.
Organon (OGN) Operating Expenses (2020 - 2026) Analysis & Trends
Organon has reported Operating Expenses for 7 years, with the latest figure at $524.0 million in Q2 2026.
- Operating Expenses for Q2 2026 came in at $524.0 million, down 4.73% year-over-year; the trailing twelve-month figure through Jun 2026 was $2.1 billion (down 7.48% YoY), and the FY2025 annual result was $2.2 billion, down 3.45% from the prior year.
- Operating Expenses declined to $524.0 million in Q2 2026, from $548.0 million in the prior quarter.
- Over five years, Operating Expenses peaked at $1.5 billion in Q4 2023 and troughed at $499.0 million in Q3 2025.
- A 5-year average of $941.9 million and a median of $866.5 million in 2022 frame the typical range for Operating Expenses.
- The widest annual swing landed in 2023, when Operating Expenses grew 15.82%; it then slumped 64.42% in 2024.
- A 5-year view of Operating Expenses shows it stood at $1.4 billion in 2022, then gained by 8.73% to $1.5 billion in 2023, then tumbled by 59.3% to $608.0 million in 2024, then declined by 12.66% to $531.0 million in 2025, then declined by 1.32% to $524.0 million in 2026.
- Per Business Quant data, the three most recent Operating Expenses figures were $524.0 million in Q2 2026, $548.0 million in Q1 2026, and $531.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn | 10.12 Bn |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn | 10.56 Bn |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn | 12.80 Bn |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn | 6.09 Bn |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn | 9.70 Bn |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn | 6.54 Bn |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn | 18.20 Bn |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 6.68 Bn |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn | -7.60 Bn |
| 10 | Organon | 3.61 Bn | 2.47 Bn | 847.00 Mn | 524.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 524.00 Mn |
| Mar 31, 2026 | 548.00 Mn |
| Dec 31, 2025 | 531.00 Mn |
| Sep 30, 2025 | 499.00 Mn |
| Jun 30, 2025 | 550.00 Mn |
| Mar 31, 2025 | 602.00 Mn |
| Dec 31, 2024 | 608.00 Mn |
| Sep 30, 2024 | 512.00 Mn |
| Jun 30, 2024 | 553.00 Mn |
| Mar 31, 2024 | 1.39 Bn |
| Dec 31, 2023 | 1.49 Bn |
| Sep 30, 2023 | 1.44 Bn |
| Jun 30, 2023 | 1.35 Bn |
| Mar 31, 2023 | 1.30 Bn |
| Dec 31, 2022 | 1.37 Bn |
| Sep 30, 2022 | 1.26 Bn |
| Jun 30, 2022 | 1.30 Bn |
| Mar 31, 2022 | 1.13 Bn |
| Dec 31, 2021 | 1.37 Bn |
| Sep 30, 2021 | 1.21 Bn |